Introduction into European market access for medical technologies
This online on-demand 3-hour seminar gives a comprehensive overview of key concepts in market access for medical devices in Europe. Available as pre-recorded webinar or full presentation in Acrobat PDF
Market access is a complex discipline that includes topics of reimbursement, funding, health technology assessment, clinical epidemiology, and stakeholder engagement.
At the moment, there is no good introductory training in market access for medical devices in Europe. Market access professionals develop an understanding of the disciple through work experience and conferences.
European Med Tech and IVD Reimbursement Consulting bridged the gap with a seminar, aimed to give a brief, but comprehensive understanding of core concepts in the field of market access for medical devices in Europe.
The seminar includes general concepts of market access as well as some specifics of the market access situation in 10 EU countries (Austria, Belgium, England, France, Germany, Italy, Netherlands, Norway, Sweden and Switzerland).
This course is suitable for market access professionals as well as those new to the subject.
What topics are reviewed?
Reimbursement, payment mechanisms, DRG system
Common payment mechanisms for hospital and ambulatory services, procedural and diagnosis classifications, principles of functioning of DRG system, example of development of DRG system for TAVI
Innovation payment schemes
Review of 15 innovative payment schemes in Europe (Austria, Belgium, England, France, Germany, Netherlands and Switzerland). For each scheme, objective and brief overview, key statistics and implications for industry is provided
Funding and willingness to pay
A brief overview of the concept of funding and funding frameworks in individual European countries (e.g. commissioning policies of NHS England, "New methods" framework in Norway)
Role of clinical and economic evidence
General requirements for clinical and economic evidence for medical devices, general tips for planning and execution of clinical trials with focus on reimbursement stakeholders
Health technology assessment
A brief overview of HTA methodology, connection of HTA with reimbursement and funding decisions, role of EUnetHTA
Stakeholder engagement, reimbursement pathways
Considerations for stakeholder management and effective market access strategy, overview of selective reimbursement pathways and complexity of achieving reimbursement
How is the seminar delivered?
Option #1: Pre-recorded webinar
One option is to watch the seminar, which is provided as a pre-recorded webinar. The duration of the webinar is 3 hours. Seminar is available for 6 months
Option #2: Presentation in Acrobat PDF
You can also access just the educational material - the full presentation of the seminar in Acrobat PDF
View extract from the seminar
This 2-minute extract presents part of the overview of the coding for medical procedures in Europe
Request a quote
Click the button below to request a quote for the seminar
